Stem Cell Banking Market

Stem Cell Banking Market by Source (PSC, BMSC, ADSC, hESC, DPSC, NSC), Service Type (Sample Processing, Analysis, Collection, Storage), Application (Personalized Storage, Clinical (Autoimmune, Hematopoietic Disorders), Research) - Global Forecasts to 2023

Report Code: BT 4447 May, 2018, by marketsandmarkets.com

[124 Pages Report] The global stem cell banking market is projected to reach USD 9,415.4 million by 2023 from USD 6,290.6 million in 2018, at a CAGR of 8.4% from 2018 to 2023. Factors such as the growing awareness on the therapeutic potential of stem cells; development of novel technologies for stem cell preservation, processing and storage; increase in hematopoietic stem cell transplantation (HSCT) procedures; and increasing investments in stem cell-based research are driving the growth of the stem cell banking market. However, the high operational costs associated with stem cell banking and stringent regulatory frameworks are expected to restrain market growth to a certain extent.

Stem Cell Banking Market

By source, the placental stem cells segment is expected to be the largest segment of the market

Based on source, the stem cell banking market is segmented into placental, embryonic, bone marrow, adipose tissue, dental pulp, and other stem cell sources. Of all these segments, the placental stem cells segment is expected to account for the largest share of 73.9% of the stem cell banking market in 2018. The large share of this segment can largely be attributed to the significant rise in the number of placental and cord banks across major markets (especially the US and Europe) coupled with growing public awareness about the therapeutic potential of stem cell sources.

By application, the personalized banking applications segment is expected to grow at the highest rate during the forecast period

Based on application, the stem cell banking market is categorized into three major segments, namely, clinical applications, research applications, and personalized banking applications. The personalized banking applications segment is expected to account for the largest share and grow at the fastest CAGR in the stem cell banking in 2018. This is attributed to the premium pricing of service plans charged by service providers and specific advantages offered by personalized banking over community & public banking (such as exclusive member rights for stored stem cells as well as efficient quality analysis, sample testing, and sample processing.

Stem Cell Banking Market

North America dominated the market in 2017

North America is expected to account for the largest share of the global stem cell banking market in 2018, followed by Asia Pacific. Factors such as expanding network of stem cell banking services across the region, ongoing approval of stem cell lines for disease treatment (especially for hematopoietic & autoimmune disorders), recent technological advancements in the field of stem cell collection and preservation techniques, and rising public-private investments for stem cell researches are driving the growth of the stem cell banking market in the North America.

Stem Cell Banking Market

Market Dynamics

Market growth is primarily driven by growing public awareness related to the therapeutic potential of stem cells; development of novel technologies for stem cell preservation, processing, and storage; rising number of hematopoietic stem cell transplantations (HSCTs); and increasing stem cell-based research. On the other hand, the high operational costs associated with stem cell banking and stringent regulatory frameworks are expected to limit market growth. The limited adoption of stem cell banking services across developing countries and socio-ethical concerns related to embryonic stem cells (ESCs) are key challenges faced by the majority of market stakeholders in the stem cell banking services industry.

Driver: Growing awareness on the therapeutic potential of stem cells

With the increased availability of clinical evidence, public awareness regarding the therapeutic potential of stem cells is on the rise across the globe. Moreover, stem cells have been proven to treat ~80 diseases and disorders including hematopoietic disorders, immunodeficiency diseases, metabolic disorders, cancer, and degenerative neuromuscular disorders. With the continued rise in per capita disposable income across developing nations and an expected decline in product costs associated with stem cell therapies, public awareness and the adoption of stem cell therapies, as well as stem cell banking services, are expected to grow during the study period.

Restraint: High operational costs of stem cell banking

Cell banks, tissue banks, and biobanks incur significant expenditure during the sample processing, quality testing, and sample preservation and storage processes. This does not include spending on the purchase and maintenance of premium-priced instruments, reagents, and consumables. This results in high operational costs for service providers. Moreover, increasingly stringent and mandatory regulatory requirements related to stem cell preservation and banking—as well as the costly licensing/approval process for the establishment of stem cell banks in developed nations—are expected to further contribute to the overall operational costs for stem cell banking service providers.

Scope of the Report

Report Metric

Details

Market Size Available for Years

2016-2023

Base Year Considered

2017

Forecast Period

2018–2023

Forecast Units

Value (USD)

Segments Covered

Source, service type application, and region

Geographies Covered

North America, Europe, APAC, and the RoW  

Companies Covered

Cord Blood Registry (CBR) Systems (US), Cordlife Group Limited (Singapore), Cryo-Cell International (US), ViaCord (US), Cryo-Save AG (Netherlands), LifeCell International (India), StemCyte (US), Global Cord Blood Corporation (China), Smart Cells International (UK), Vita34 AG (Germany), and CryoHoldco (Mexico).

This report categorizes the stem cell banking market into the following segments and subsegments:

Global Stem Cell Banking Market, by Source

  • Placental Stem Cells (PSCS)
  • Adipose Tissue-Derived Stem Cells (ADSCS)
  • Bone Marrow-Derived Stem Cells (BMSCS)
  • Human Embryo-Derived Stem Cells (HESCS)
  • Dental Pulp-Derived Stem Cells (DPSCS)
  • Other Stem Cell Sources

Global Stem Cell Banking Market, by Service Type

  • Sample Preservation and Storage
  • Sample Analysis
  • Sample Processing
  • Sample Collection and Transportation

Global Stem Cell Banking Market, By Application

  • Personalized Banking Applications
  • Research Applications
    • Disease Treatment Studies
    • Life Science Research
    • Drug Discovery
  • Clinical Application
    • Hematopoietic Disorders
    • Autoimmune Disorders
    • Other Diseases

Global Stem Cell Banking Market, by Region

  • North America
  • Europe
  • Asia Pacific
  • Rest of the World (RoW)

Key Market Players

As of 2017, the global stem cell banking market was dominated by Cord Blood Registry (CBR) Systems (US), Cordlife Group Limited (Singapore), Cryo-Cell International (US), and ViaCord (US). Other key players in the stem cell banking market included Cryo-Save AG (Netherlands), LifeCell International (India), StemCyte (US), Global Cord Blood Corporation (China), Smart Cells International (UK), Vita34 AG (Germany), and CryoHoldco (Mexico), among others.

Cord Blood Registry (CBR) Systems held the leading position in the global stem cell banking market in 2017. The company has a widespread presence and large customer base in the US. The company primarily focuses on advancing its umbilical cord preservation services through the adoption of inorganic growth strategies such as collaborations and partnerships. In regard to this, in 2017, the company collaborated with the New York Stem Cell Foundation (US) to develop induced pluripotent stem cells from umbilical cords. In addition to this, in 2015, the company entered into a strategic collaboration with Global Cord Blood Corporation (China) to integrated their methodologies for the collection, processing, and storage of umbilical cords and improve the overall stem cell banking service standards in the US and China.

Cordlife secured the second position in the global stem cell banking market in 2017. The company is a leading player in the Asian stem cell banking market with its robust presence across eight countries and high-quality services. To sustain its leading position in the Asian region, the company mainly focuses on increasing its customer base through agreements. For instance, in 2017, the company entered into an agreement with IPS Trading and Service Joint Stock Company (Vietnam) to offer umbilical cord banking services and non-invasive metabolic newborn screening in Vietnam. Similarly, in 2016, the company collaborated with Bio Secure Company Limited (Myanmar) to offer umbilical cord banking services in Myanmar.

Cryo-Cell International held the third position in the stem cell banking market in 2017. The company is one of the key private stem cell banking providers in the global market. The company’s key strengths are its significant geographic presence and unique state-of-the-art technology for banking operations. The company mainly focuses on acquiring patents for the collection, testing, processing, and preservation of umbilical cord blood and tissues. For instance, in 2015, the company acquired assets of Prepacyte-CB (a cord blood business of CytoMedical Design Group LLC) to advance its existing technology for processing of cord blood and tissues.

Recent Developments:

  • In 2017, Life Cell International (India), launched upgraded and enhanced its umbilical cord collection kit
  • In 2017, Vita34 AG (Germany) acquired Seracell Pharma AG (Germany) to strengthen its position in the German stem cell banking market.
  • In 2016, StemCyte India Therapeutics Pvt. Ltd. (India), a subsidiary of StemCyte (US) received accreditation from The Foundation for the Accreditation of Cellular Therapy (FACT) for both public and private stem cell banking services.
  • In 2015, Cord Blood Registry (CBR) Systems (US) entered into a collaboration agreement with New York Stem Cell Foundation (US) to develop induced pluripotent stem cells from umbilical cords

Key questions addressed in the report:

  • What are the growth opportunities related to stem cell banking market across major regions in the future?
  • Emerging countries have immense opportunities for the growth and adoption of stem cell banking. Will this scenario continue in the next five years?
  • What are the various types of stem cell banking services and their market share in the overall market?
  • What are the new trends and advancements in the applications segment?

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

Table of Contents

1 Introduction (Page No. - 14)
    1.1 Objectives of the Study
    1.2 Market Definition
           1.2.1 Markets Covered
           1.2.2 Geographic Scope
           1.2.3 Years Considered for the Study
    1.3 Currency Used
    1.4 Market Stakeholders

2 Research Methodology (Page No. - 18)
    2.1 Research Data
           2.1.1 Secondary Data
                    2.1.1.1 Secondary Sources
           2.1.2 Primary Data
                    2.1.2.1 Breakdown of Primaries
                    2.1.2.2 Key Data From Primary Sources
    2.2 Market Size Estimation
           2.2.1 Bottom-Up Approach
           2.2.2 Top-Down Approach
    2.3 Market Breakdown and Data Triangulation
    2.4 Research Assumptions
    2.5 Research Limitations

3 Executive Summary (Page No. - 27)

4 Premium Insights (Page No. - 31)
    4.1 Stem Cell Banking: Market Overview (2018)
    4.2 Stem Cell Banking Market, By Source (2018 vs 2023)
    4.3 Market, By Application (2018 vs 2023)
    4.4 Market, By Service Type (2018 vs 2023)
    4.5 Geographic Snapshot: Market (2018)

5 Market Overview (Page No. - 35)
    5.1 Introduction
    5.2 Market Dynamics
           5.2.1 Market Drivers
                    5.2.1.1 Growing Awareness on the Therapeutic Potential of Stem Cells
                    5.2.1.2 Development of Novel Technologies for Stem Cell Preservation, Processing, and Storage
                    5.2.1.3 Increase in HematopOIEtic Stem Cell Transplantation Procedures
                    5.2.1.4 Increasing Investments in Stem Cell-Based Research
           5.2.2 Market Restraints
                    5.2.2.1 High Operational Costs of Stem Cell Banking
                    5.2.2.2 Stringent Regulatory Frameworks
           5.2.3 Market Opportunities
                    5.2.3.1 Emerging Countries
                    5.2.3.2 Rising Global Burden of Major Diseases
           5.2.4 Market Challenge
                    5.2.4.1 Socio-Ethical Concerns Related to Embryonic Stem Cells

6 Stem Cell Banking Market, By Source (Page No. - 41)
    6.1 Introduction
    6.2 Placental Stem Cells (PSCS)
    6.3 Adipose Tissue-Derived Stem Cells (ADSCS)
    6.4 Bone Marrow-Derived Stem Cells (BMSCS)
    6.5 Human Embryo-Derived Stem Cells (HESCS)
    6.6 Dental Pulp-Derived Stem Cells (DPSCS)
    6.7 Other Stem Cell Sources

7 Stem Cell Banking Market, By Service Type (Page No. - 49)
    7.1 Introduction
    7.2 Sample Preservation and Storage
    7.3 Sample Analysis
    7.4 Sample Processing
    7.5 Sample Collection and Transportation

8 Stem Cell Banking Market, By Application (Page No. - 56)
    8.1 Introduction
    8.2 Personalized Banking Applications
    8.3 Research Applications
           8.3.1 Disease Treatment Studies
           8.3.2 Life Science Research
           8.3.3 Drug Discovery
    8.4 Clinical Applications
           8.4.1 HematopOIEtic Disorders
           8.4.2 Autoimmune Disorders
           8.4.3 Other Diseases

9 Stem Cell Banking Market, By Region (Page No. - 67)
    9.1 Introduction
    9.2 North America
    9.3 Europe
    9.4 Asia Pacific
    9.5 RoW

10 Competitive Landscape (Page No. - 90)
     10.1 Overview
     10.2 Global Market Ranking Analysis (2017)
     10.3 Competitive Scenario
             10.3.1 Agreements, Partnerships, and Collaborations
             10.3.2 Mergers and Acquisitions
             10.3.3 Service Launches and Enhancements
             10.3.4 Other Developments

11 Company Profile (Page No. - 94)
(Overview, Services Offered, Recent Developments, MnM View)*
     11.1 Cord Blood Registry Systems
     11.2 Cordlife
     11.3 Cryo-Cell International
     11.4 Cryo-Save AG (A Subsidiary of Esperite N.V)
     11.5 LifeCell International
     11.6 StemCyte
     11.7 ViaCord (A Subsidiary of Perkinelmer)
     11.8 Global Cord Blood
     11.9 Smart Cells International
     11.10 Vita34
     11.11 CryoHoldco

* Overview, Services Offered, Recent Developments, MnM View Might Not Be Captured in Case of Unlisted Companies.

12 Appendix (Page No. - 116)
     12.1 Discussion Guide*
     12.2 Knowledge Store: Marketsandmarkets’ Subscription Portal
     12.3 Introducing RT: Real-Time Market Intelligence
     12.4 Available Customizations
     12.5 Related Reports
     12.6 Author Details


List of Tables (58 Tables)

Table 1 Operational/Procedural Costs Associated With Stem Cell Banking in the Us (2012)
Table 2 Market, By Source, 2016–2023 (USD Million)
Table 3 Market for Placental Stem Cells, By Region, 2016–2023 (USD Million)
Table 4 Market for Adipose Tissue-Derived Stem Cells, By Region, 2016–2023 (USD Million)
Table 5 Market for Bone Marrow-Derived Stem Cells, By Region, 2016–2023 (USD Million)
Table 6 Market for Human Embryo-Derived Stem Cells, By Region, 2016–2023 (USD Million)
Table 7 Market for Dental Pulp-Derived Stem Cells, By Region, 2016–2023 (USD Million)
Table 8 Market for Other Stem Cell Sources, By Region, 2016–2023 (USD Million)
Table 9 Market, By Service Type, 2016-2023 (USD Million)
Table 10 Market for Sample Preservation and Storage, By Region, 2016-2023 (USD Million)
Table 11 Market for Sample Analysis, By Region, 2016-2023 (USD Million)
Table 12 Market for Sample Processing, By Region, 2016-2023 (USD Million)
Table 13 Market for Sample Collection and Transportation, By Region, 2016-2023 (USD Million)
Table 14 Market, By Application, 2016–2023 (USD Million)
Table 15 Market for Personalized Banking Applications, By Region, 2016–2023 (USD Million)
Table 16 Global Market for Research Applications, By Type, 2016–2023 (USD Million)
Table 17 Market for Research Applications, By Region, 2016–2023 (USD Million)
Table 18 Market for Disease Treatment Studies, By Region, 2016–2023 (USD Million)
Table 19 Market for Life Science Research, By Region, 2016–2023 (USD Million)
Table 20 Market for Drug Discovery, By Region, 2016–2023 (USD Million)
Table 21 Global Market for Clinical Applications, By Disease Area, 2016–2023 (USD Million)
Table 22 Market for Clinical Applications, By Region, 2016–2023 (USD Million)
Table 23 Market for Hematopoietic Disorders, By Region, 2016–2023 (USD Million)
Table 24 Market for Autoimmune Disorders, By Region, 2016–2023 (USD Million)
Table 25 Market for Other Diseases, By Region, 2016–2023 (USD Million)
Table 26 Market, By Region, 2016–2023 (USD Million)
Table 27 Market, By Region (Units Stored)
Table 28 Market, By Country, 2016–2023 (USD Million)
Table 29 North America: Market, By Country, 2016–2023 (USD Million)
Table 30 North America: Market, By Country (Units Stored)
Table 31 North America: Market, By Source, 2016–2023 (USD Million)
Table 32 North America: Market, By Service Type, 2016–2023 (USD Million)
Table 33 North America: Market, By Application, 2016–2023 (USD Million)
Table 34 North America: Market for Clinical Applications, By Disease Area, 2016–2023 (USD Million)
Table 35 North America: Market for Research Applications, By Type, 2016–2023 (USD Million)
Table 36 Europe: Market, By Country, 2016–2023 (USD Million)
Table 37 Europe: Market, By Country (Units Stored)
Table 38 Europe: Market, By Source, 2016–2023 (USD Million)
Table 39 Europe: Market, By Service Type, 2016–2023 (USD Million)
Table 40 Europe: Market, By Application, 2016–2023 (USD Million)
Table 41 Europe: Market for Clinical Applications, By Disease Area, 2016–2023 (USD Million)
Table 42 Europe: Market for Research Applications, By Type, 2016–2023 (USD Million)
Table 43 Asia Pacific: Market, By Country, 2016–2023 (USD Million)
Table 44 Asia Pacific: Market, By Country (Units Stored)
Table 45 Asia Pacific: Market, By Source, 2016–2023 (USD Million)
Table 46 Asia Pacific: Market, By Service Type, 2016–2023 (USD Million)
Table 47 Asia Pacific: Market, By Application, 2016–2023 (USD Million)
Table 48 Asia Pacific: Market for Clinical Applications, By Disease Area, 2016–2023 (USD Million)
Table 49 Asia Pacific: Market for Research Applications, By Type, 2016–2023 (USD Million)
Table 50 RoW: Market, By Source, 2016–2023 (USD Million)
Table 51 RoW: Market, By Service Type, 2016–2023 (USD Million)
Table 52 RoW: Market, By Application, 2016–2023 (USD Million)
Table 53 RoW: Market for Clinical Applications, By Disease Area, 2016–2023 (USD Million)
Table 54 RoW: Market for Research Applications, By Type, 2016-2023 (USD Million)
Table 55 Major Agreements, Partnerships, and Collaborations (2015–2018)
Table 56 Major Mergers and Acquisitions (2015–2018)
Table 57 Major Service Launches and Enhancements (2015–2018)
Table 58 Other Major Developments (2015–2018)
 
 
List of Figures (31 Figures)
 
Figure 1 Global Market: Research Methodology Steps
Figure 2 Research Design
Figure 3 Market: Bottom-Up Approach
Figure 4 Market: Top-Down Approach
Figure 5 Data Triangulation Methodology
Figure 6 Placental Stem Cells Segment to Dominate the Global Stem Cell Banking Market During the Forecast Period
Figure 7 Personalized Banking Applications to Witness the Highest Growth During the Forecast Period (2018–2023)
Figure 8 Sample Preservation and Storage to Be the Fastest-Growing Segment of the Stem Cell Banking Services Market During 2018–2023
Figure 9 Asia Pacific to Witness Fastest Growth for Stem Cell Banking Services During the Forecast Period
Figure 10 Rising Awareness on the Therapeutic Potentials of Stem Cells to Drive the Global Market During the Forecast Period
Figure 11 Placental Stem Cells is Poised to Be the Key Cell Type in Global Stem Cell Banking Market During the Forecast Period
Figure 12 Personalized Banking Applications to Dominate the Market in 2023
Figure 13 Sample Preservation and Storage Services to Be the Fastest-Growing Segment During the Forecast Period
Figure 14 North America to Dominate the Global Market During the Forecast Period
Figure 15 Market: Drivers, Restraints, Opportunities, and Challenges
Figure 16 Placental Stem Cells Segment to Dominate the Global Market During the Forecast Period
Figure 17 Market, By Service Type (2018 vs 2023)
Figure 18 Personalized Banking Applications to Witness the Highest Growth During the Forecast Period (2018–2023)
Figure 19 Geographic Snapshot: Asia Pacific to Register the Highest CAGR in Market During the Forecast Period
Figure 20 North America: Market Snapshot
Figure 21 Europe: Market Snapshot
Figure 22 Asia Pacific: Market Snapshot
Figure 23 RoW: Market Snapshot
Figure 24 Global Market Ranking Analysis, By Key Service Providers (2017)
Figure 25 AMAG Pharmaceuticals: Company Snapshot (2017)
Figure 26 Cordlife: Company Snapshot (2017)
Figure 27 Cryo-Cell International: Company Snapshot (2017)
Figure 28 Esperite: Company Snapshot (2016)
Figure 29 Perkinelmer: Company Snapshot (2016)
Figure 30 Global Cord Blood: Company Snapshot (2017)
Figure 31 Vita34 AG : Company Snapshot (2017)


Request for detailed methodology, assumptions & how numbers were triangulated.

Please share your problem/objectives in greater details so that our analyst can verify if they can solve your problem(s).
2 6 4 5 8  
  • Select all
  • News-Letters with latest Market insights
  • Information & discussion on the relevant new products and services
  • Information & discussion on Market insights and Market information
  • Information & discussion on our events and conferences
    • Select all
    • Email Phone Professional and social network (Linkedin, etc)
COVID-19

Get in-depth analysis of the COVID-19 impact on the Stem Cell Banking Market

Benchmarking the rapid strategy shifts of the Top 100 companies in the Stem Cell Banking Market

Request For Special Pricing
Report Code
BT 4447
Published ON
May, 2018
Choose License Type
BUY NOW
  • SHARE
X
Request Customization
Speak to Analyst
Speak to Analyst
OR FACE-TO-FACE MEETING
PERSONALIZE THIS RESEARCH
  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
REQUEST A FREE CUSTOMIZATION
LET US HELP YOU!
  • What are the Known and Unknown Adjacencies Impacting the Stem Cell Banking Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
CUSTOMIZED WORKSHOP REQUEST
ADJACENT MARKETS
REQUEST BUNDLE REPORTS
+1-888-600-6441
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
CONNECT WITH US
ABOUT TRUST ONLINE
©2020 MarketsandMarkets Research Private Ltd. All rights reserved
...

Digital Virtual Assistant - MarketsandMarkets

Home